SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-013346
Filing Date
2012-03-07
Accepted
2012-03-06 20:40:33
Documents
17
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v303459_10k.htm 10-K 1581426
2 EXHIBIT 3.1 v303459_ex3-1.htm EX-3.1 138383
3 EXHIBIT 10.5 v303459_ex10-5.htm EX-10.5 11932
4 EXHIBIT 21.1 v303459_ex21-1.htm EX-21.1 3798
5 EXHIBIT 23.1 v303459_ex23-1.htm EX-23.1 2433
6 EXHIBIT 24.1 v303459_ex24-1.htm EX-24.1 9493
7 EXHIBIT 31.1 v303459_ex31-1.htm EX-31.1 7667
8 EXHIBIT 31.2 v303459_ex31-2.htm EX-31.2 7724
9 EXHIBIT 32.1 v303459_ex32-1.htm EX-32.1 3575
10 EXHIBIT 32.2 v303459_ex32-2.htm EX-32.2 3474
11 GRAPHIC chart.jpg GRAPHIC 57532
  Complete submission text file 0001144204-12-013346.txt   4333176

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT navb-20111231.xml EX-101.INS 355721
13 XBRL TAXONOMY EXTENSION SCHEMA navb-20111231.xsd EX-101.SCH 22810
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE navb-20111231_cal.xml EX-101.CAL 55684
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20111231_def.xml EX-101.DEF 140143
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20111231_lab.xml EX-101.LAB 187547
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20111231_pre.xml EX-101.PRE 166726
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35076 | Film No.: 12672264
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences